Related references
Note: Only part of the references are listed.Intestinal peroxisome proliferator-activated receptor α-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis
Tingting Yan et al.
HEPATOLOGY (2023)
ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activity
Anne Fougerat et al.
CELL REPORTS (2022)
Reduction in gut-derived MUFAs via intestinal stearoyl-CoA desaturase 1 deletion drives susceptibility to NAFLD and hepatocarcinoma
Simon Ducheix et al.
HEPATOLOGY COMMUNICATIONS (2022)
Pcsk9 Deletion Promotes Murine Nonalcoholic Steatohepatitis and Hepatic Carcinogenesis: Role of Cholesterol
George N. Ioannou et al.
HEPATOLOGY COMMUNICATIONS (2022)
Role of Cholesterol-Associated Steatohepatitis in the Development of NASH
Christian L. Horn et al.
HEPATOLOGY COMMUNICATIONS (2022)
Structural insights into the mechanism of human NPC1L1-mediated cholesterol uptake
Miaoqing Hu et al.
SCIENCE ADVANCES (2021)
Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis
Xiaobo Wang et al.
CELL METABOLISM (2020)
Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators
Elena Piccinin et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Time-Dependent Molecular Responses Differ between Gastric Bypass and Dieting but Are Conserved Across Species
Danny Ben-Zvi et al.
CELL METABOLISM (2018)
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra et al.
JOURNAL OF HEPATOLOGY (2018)
LXR Suppresses Inflammatory Gene Expression and Neutrophil Migration through cis-Repression and Cholesterol Efflux
David G. Thomas et al.
CELL REPORTS (2018)
Selective Chemical Inhibition of PGC-1α Gluconeogenic Activity Ameliorates Type 2 Diabetes
Kfir Sharabi et al.
CELL (2017)
Peroxisome Proliferator-activated Receptor-γ Coactivator 1-α (PGC1α) Protects against Experimental Murine Colitis
Kellie E. Cunningham et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Ezetimibe for the Treatment of Nonalcoholic Steatohepatitis: Assessment by Novel Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Randomized Trial (MOZART Trial)
Rohit Loomba et al.
HEPATOLOGY (2015)
Novel effect of ezetimibe to inhibit the development of non-alcoholic fatty liver disease in Fatty Liver Shionogi mouse
Xiang Wang et al.
HEPATOLOGY RESEARCH (2014)
Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis
George N. Ioannou et al.
JOURNAL OF LIPID RESEARCH (2013)
Niemann-Pick C1-Like 1 (NPC1L1) Protein in Intestinal and Hepatic Cholesterol Transport
Lin Jia et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 73 (2011)
Bax is necessary for PGC1α pro-apoptotic effect in colorectal cancer cells
Ilenia D'Errico et al.
CELL CYCLE (2011)
Modulation of Longevity and Tissue Homeostasis by the Drosophila PGC-1 Homolog
Michael Rera et al.
CELL METABOLISM (2011)
Rosiglitazone-Induced Mitochondrial Biogenesis in White Adipose Tissue Is Independent of Peroxisome Proliferator-Activated Receptor γ Coactivator-1α
Rosario Pardo et al.
PLOS ONE (2011)
Human NPC1L1 Expression is Positively Regulated by PPARα
Yuki Iwayanagi et al.
PHARMACEUTICAL RESEARCH (2011)
Peroxisome proliferator-activated receptor-γ coactivator 1-α (PGC1α) is a metabolic regulator of intestinal epithelial cell fate
Ilenia D'Errico et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Intestinal Specific LXR Activation Stimulates Reverse Cholesterol Transport and Protects from Atherosclerosis
Giuseppe Lo Sasso et al.
CELL METABOLISM (2010)
Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet
Dick C. Chan et al.
DIABETES CARE (2010)
NPC1L1 and cholesterol transport
Jenna L. Betters et al.
FEBS LETTERS (2010)
Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study
Masato Yoneda et al.
HEPATOLOGY RESEARCH (2010)
NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease
Munechika Enjoji et al.
LIPIDS IN HEALTH AND DISEASE (2010)
Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease
Yuichi Nozaki et al.
JOURNAL OF HEPATOLOGY (2009)
HNF4α is a crucial modulator of the cholesterol-dependent regulation of NPC1L1
Yuki Iwayanagi et al.
PHARMACEUTICAL RESEARCH (2008)
Partnership of PGC-1α and HNF4α in the regulation of lipoprotein metabolism
James Rhee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia
JP Davies et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Niemann-Pick C1 like 1 protein is critical for intestinal cholesterol absorption
SW Altmann et al.
SCIENCE (2004)
Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles
A Grefhorst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors α and β
JJ Repa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption
SW Altmann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ
JJ Repa et al.
GENES & DEVELOPMENT (2000)
The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes
RB Vega et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
